Clinical Trial Update: CD19-targeted CAR-T Cell Therapy for MRD+ B-cell Malignancies After Autologous Stem Cell Transplantation [NA]

View source ↗

Summary

This clinical trial update discusses a CD19-targeted CAR-T cell therapy approach for minimal residual disease–positive B-cell lymphoma or leukemia after autolog…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• B-cell Leukemia
• B-cell Lymphoma

Drugs mentioned

• CD19-targeted CAR-T cell therapy

Snippet

Sponsor: Qingdao Central Hospital | Conditions: Lymphoma, B-Cell, Leukemia, B-Cell | NA | Status: UNKNOWN